Skip over navigation
Directory
Directory Search
Jobs
Job Search
Post a Job
Patient
Patient Resources
Drug Development
History
Genealogy
Toons & Teasers
About
Advertising
Home
Quick Links
Directory
Job Search
Toons & Teasers
Advertising
LifeScienceHistory.com - Check us out on Instagram
Industry News
Search Articles:
Catalyst Bio reports updated data from phase 2/3 trial of subcutaneous marzeptacog alfa
Catalyst Biosciences reported updated interim data from the Phase 2/3 trial of subcutaneous prophylactic Factor VIIa variant marzeptacog alfa (activated) (MarzAA) currently being developed for treatment of hemophilia A or B with inhibitors.
February 08, 2019
More...
Email This Page
to a Friend
Print This
Page